Abstract-Glioblastoma multiforme is one of the deadliest human cancers and is characterized by tumor cells that hijack immune system cells in a deadly symbiotic relationship. Microglia and glioma infiltrating macrophages, which in principle should mount an immune response to the tumor, are subverted by tumor cells to facilitate growth in several ways. In this study, we seek to understand the interactions between the tumor cells and the microglia that enhance tumor growth, and for this purpose, we develop a mathematical and computational model that involves reactiondiffusion equations for the important components in the interaction. These include the densities of tumor and microglial cells, and the concentrations of growth factors and other signaling molecules. We apply this model to a transwell assay used in the laboratory to demonstrate that microglia can stimulate tumor cell invasion by secreting the growth factor TGF-β. We show that the model can both replicate the major components of the experimental findings and make new predictions to guide future experiments aimed at the development of new therapeutic approaches. Sensitivity analysis is used to identify the most important parameters as an aid to future experimental work. This study is the first step in a program that involves development of detailed 3-D models of the mechanical and biochemical interactions between a glioblastoma and the tumor microenvironment.
regulation and signaling networks involved in cell proliferation and survival have been studied by many, but there is little understanding of how the chemical and mechanical signals from the TME interact to affect tumor progression. Here, we study one aspect of this question in the context of brain tumors.
Most brain cancers are malignant gliomas, the most aggressive form of which is called glioblastoma multiforme (GBM). These tumors are highly invasive, and they spread rapidly, which makes them difficult to completely remove surgically. GBM tumors stem from glial cells, a class of neural cells that includes both astrocytes and resident brain macrophages (microglia). Glioma infiltrating macrophages (GIMs) can comprise up to one third of the total tumor mass [1] , and apparently, originate from both microglia and monocyte-derived macrophages from the circulation [2] . Activated GIMs exhibit two distinct phenotypes: the classically activated, tumor-suppressive type (M1), and an alternatively activated, tumor promoting, immunosuppressive type (M2) [3] . The balance between these phenotypes is usually tilted to the M2 form [4] , and numerous factors secreted by glioma cells, including growth factors, chemokines, cytokines and matrix proteins, can influence GIM recruitment and phenotypic switching [5] , [6] .
Transforming growth factor beta (TGF-β) is one of the growth factors involved in maintenance of tissue homeostasis. The receptor for TGF-β is a heterotetramer of dimeric Type I and Type II receptors, and occupation leads to phosphorylation of transcription factors in the SMAD family [7] (cf., Fig. 1 ). Normally TGF-β acts to control growth via its effect on the cell cycle, but when upregulated in GBM tumors it stimulates growth [8] . TGF-β also acts to stimulate glioma cell migration, as shown in a transwell assay described in Fig. 2(A) . When microglia are plated in the bottom chamber, TGF-β acts as a chemotactic attractant for glioma cells in the upper chamber, and silencing of the Type II receptor on glioma cells with shRNAs abolishes their migration [9] . More recent work has shown that the stimulative effect on invasiveness primarily acts on the stem-cell-like tumor sub-population [10] .
Other growth factors such as epidermal growth factor (EGF) and colony stimulating factor-1 (CSF-1) are also important in tumor development. GIMs require CSF-1 for survival, and it enhances the phenotypic M1 → M2 transition as well [11] . This is one step in a paracrine signaling loop in which CSF-1 released by tumor cells stimulates GIMs to express EGF and infiltrate the tumor, and the EGF in turn acts on the tumor cells to promote their invasiveness. Blocking the CSF-1R receptor on GIMs inhibits their enhancement of tumor cell invasion Fig. 1 . Interaction of the CSF-1, EGF, and TGF-pathways in the control of cell proliferation and invasion in glioblastoma. In normal cells, these pathways are balanced so as to control growth, but in gliomas increased secretion of CSF-1 by tumor cells induces the M1 → M2 transformation of the microglia and stimulates their secretion of EGF. This disrupts the proliferation-inhibition mechanism by partially blocking the TGF-Smad pathway and stimulates proliferation and invasion.
[5], [12] . Proteases such as matrix metalloproteinase-2 (MMP-2) that degrade the ECM also play a role in dispersal of GBM cells, in that tumor cells induce GIMs to secrete MMP-2 [13] .
Many biochemical and mechanical processes underlie the interactions in Fig. 1 , and it would be difficult to develop a comprehensive model of the TME that incorporates all of them. As a first step, we focus here on one aspect for which there is experimental data-the chemotactic response of tumor cells to TGF-β. We develop a model based on reaction-diffusion equations that govern cell-cell signaling and cell dispersal with the goal of understanding the factors that are important in determining the chemotactic movement of glioma cells from the upper to the lower well of the Boyden chamber assay shown in Fig. 2(A) . We show that the model can reproduce many of the experimental observations and we make predictions as to how various interventions can affect the outcome.
II. MATHEMATICAL MODEL FOR TRANSWELL EXPERIMENTS
The geometries of the experimental and computational domains are shown in Fig. 2 , and details of the experimental and computational setup are given in the figure caption. The mathematical model involves the densities of glioma cells (n), of M1 and M2 microglia (m 1 and m 2 ), and of the ECM (ρ), as well as the concentration of CSF-1 (C), of EGF (E), of TGF-β(G), and of MMPs (P ), all a function of (x, t). The evolution equations for these components are developed in generality in the following, but in this paper, we focus on the transwell assay in one space dimension.
A. Glioma Cell Density (= n(x, t))
The mass balance equation for the tumor cell density n(x, t) is where J n is the flux and P n is the net production rate of glioma cells. The flux J n is comprised of three parts, J random , J chem o , and J hapto , which are the fluxes due to random motion, chemotaxis, and haptotaxis, respectively [14] . We assume that the ECM is homogeneous and isotropic, and that the flux due to the random component of motility is given by
where D n is the diffusion coefficient, which is assumed to be constant. In brain tissue, glioma cells are strongly chemotactic to TGF-β [15] , and therefore, the chemotactic flux is assumed to be of the form
where χ n is the chemotactic sensitivity and λ G is a scaling parameter. This form reduces to the standard form under small gradients and saturates under large gradients. Glioma invasiveness is enhanced by proteolytic degradation of the ECM via MMPs that are produced by glioma cells a the TGF-β-SMAD-E-cadherin-MMP pathway [9] , [16] . This leads to local degradation of ECM [14] and movement in the direction of the gradient ∇ρ via a process called haptotaxis. We represent the haptotactic flux as
where χ 1 n is the haptotactic sensitivity and λ ρ is a scaling parameter.
The production of tumor cells is due to active EGF-stimulated growth, which we represent as follows:
where a 1 is the proliferation rate of tumor cells in the absence of EGF, k E , l are Hill-function parameters for activation of proliferation in the presence of EGF, and κ(x) is the space-dependent carrying capacity of the tumor in a given tumor environment
. Combining the fluxes and growth term leads to the governing equation for the tumor cells
B. Densities of M1 (= m 1 (x, t)) and M2 (= m 2 (x, t)) Type Microglia
The evolution of the densities of microglia follows reactiondiffusion equations similar to those for tumor cells, but with the following assumptions.
1) Activated M2-but not M1-cells are chemotactic to the CSF-1 secreted by tumor cells [5] , and the flux is of the form (3), but with a different sensitivity. Since the microglia produce TGF-β (see later references), the movement of activated microglia further enhances glioma invasiveness via the TGF-β-SMAD-E-cadherin-MMP pathway described earlier.
2) The inactive (M1) microglia transform into the active M2 type at the rate a 3 in the presence of CSF-1. 3) (Both phenotypes proliferate-with rate constants a 2 and a 4 , respectively. This leads to following evolution equations:
C. Tumor ECM Density (=ρ(x, t))
The tumor ECM provides structural support for cell migration, but it must also be degraded for cell migration by proteases such as the tumor-secreted MMPs. The rate of tumor ECM change can be expressed as
for ρ > 0, and 0 otherwise. Here, d ρ is the degradation rate by MMPs secreted by tumor cells. This equation describes degradation when there is a significant level of ECM present, as is normally the case.
D. CSF-1 Concentration (= C(x, t))
Glioma cells secrete CSF-1 in order to recruit the stromal cells such as microglia [5] . CSF-1 is also needed for the activation of M1 into the aggressive M2 type, which in turn promotes tumor cell invasion [5] , [9] , [17] , [18] . Thus, the governing equation
where a 5 is the secretion rate of CSF-1 by glioma cells and d C is the decay rate of CSF-1.
E. EGF Concentration (= E(x, t))
We take into account diffusion, secretion, and first-order decay in the system. Activated microglia and macrophages are the major source of EGF in gliomas, and thus, the governing equation for EGF is
where a 6 and B 1 a 6 are secretion rates of EGF by M1 type and M2 type of microglia, respectively, and d E is the decay rate of EGF. Here, a 6 1, B 1 1.
F. TGF-β Concentration (= G(x, t))
Activated microglia and macrophages are the primary source of TGF-β in experimental rat gliomas or after brain injury [9] , [19] , [20] , and the gradients created by diffusion promote chemotactic movement of tumor cells. In addition to diffusive transport of TGF-β, there is a convective flux due to chemotactic movement of the microglia in response to CSF-1, but this is neglected here, and thus, the governing equation for TGF-β is as follows:
where a 7 and B 2 a 7 are secretion rates of TGF-β by M1 and M2 types of microglia, respectively, B 2 is a scaling parameter, and d G is the decay rate. We assume that a 7 1 and B 2 1.
G. MMP Concentration (= P (x, t))
We suppose that glioma cells secrete MMPs for degradation of the ECM in response to TGF-β signaling from microglia, as found in [9] and [16] . It was also shown that antibody against TGF-β receptors blocks this effect in invasion assays [9] . Thus
where a 9 is the MMP production rate by glioma cells, B 3 is a scale factor, d P is the decay rate of MMPs, I(·) is the indicator function, and th G is a threshold value for activation of MMP secretion. In general, the diffusion coefficient of MMPs is very small (D P 1) and the half life of MMPs is short (μ P 1) [21] .
H. Boundary Conditions and Initial Conditions
In the following simulations, we prescribe Neumann boundary conditions on the exterior boundary Γ 1 (cf., Fig. 2 ).
where ν is the unit outer normal vector. The membrane is permeable to all variables (n, m 1 , m 2 , C, E, G, P ), but not freely so. We describe the flux at Γ 2 for these variables
where
and the parameter γ i (i = 1, . . . , 8) is determined by the size and density of the holes (see [22] for the derivation of these boundary conditions by the method of homogenization). If the size or density of the holes in the membrane is increased, the membrane becomes more permeable, and γ i increases. The entire system of (6)- (15) can be put into nondimensional form for use in the simulations. This is done in the supplemental material and the parameters are defined there. Hereafter, we restrict the computational domain to one space dimension, and the domain is scaled to unit length.
III. COMPUTATIONAL RESULTS
In this section, we compare the predictions of the mathematical model with experimental observations, and then, suggest a therapeutic strategy for blocking invasive glioma cells.
A. Predictions of the Computational Model
The density profiles of all variables in the model are shown in Fig. 3 at t = 0, 18, 36 h in the presence of M1/M2 microglia in the lower chamber. Here, the right half of the domain corresponds to the upper chamber in the transwell. By digesting the ECM, tumor cells in the upper chamber can invade the lower chamber and interact with M1/M2 cells. Tumor cells secrete Fig. 3(A) and (B) ]. As they invade, they detect higher levels of EGF and TGF-β, and proliferate at a higher rate.
A comparison of simulation results with experimental results is shown in Fig. 4 . After 36 h, the number of glioma cells invading the lower chamber doubled in the coculture with microglial cells [Neg/9+microglia in Fig. 4(A) ] in the lower chamber as compared to the control [Neg/9 in Fig. 4(A) ] [9] . In the simulations, the number of invading glioma cells increased ∼ twofold in the presence of M1/M2 microglia in the lower chamber (+MG in Fig. 4(B) relative to the control [absence of microglia; −MG in Fig. 4(B) ]. As Wesolowska et al. [9] remark, tumor cells invade the lower chamber even in the absence of microglia in the chamber, which demonstrates the intrinsic invasiveness of these cells.
In Fig. 5 , we investigate the effect of antibody against TGF-β on tumor invasion. In the experiments, Wesolowska et al. [9] found that the neutralizing antibody (Ab) abrogated the invasion-promoting effect of microglia in the lower chamber, i.e., the number of migrating cells was reduced in the presence of the antibody (+MG+Ab) when compared to the MG case in the absence of the antibody (+MG-Ab). Wesolowska et al. The results shown are from three independent experiments, each in triplicate, in which the invading glioma cells were stained with DAPI (4 ,6-diamidino-2-pheylindole) [9] . (B) Simulation results showing how the number of migrating glioma cells increases in the presence of M1/M2 microglia (+MG) in the lower chamber compared to the absence of microglia (-MG). [9] showed that a knockdown of TGF-βtype II receptor (TβIIR) by plasmid-transcribed shRNA can effectively inhibit TGF-β signaling and transcriptional responses, thus, blocking invasiveness of human glioblastoma cells. They also found that a stable knockdown of TβIIR expression can impair growth of gliomas in nude mice. The mathematical model also predicts that the invasiveness of tumor cells is inhibited in the presence of antibody against TGF-β(+MG+Ab) relative to control cases: −MG-Ab (no M1/M2 in the lower chamber; no antiboy), +MG-Ab (M1/M2 in the lower chamber; no antibody). See Fig. 5(B) . However, one should note that this antibody, or TGF-β blocking, is not enough to completely block the aggressive invasion of glioma cells, since they invade in the absence of microglia.
The results of computational studies on the effect of haptotaxis and chemotaxis of glioma cells on cell infiltration into the lower chamber are shown in Fig. 6 . This shows the tumor density (A) and the populations of invasive glioma cells (B) at t = 36 h as a function of the chemotactic sensitivity χ n . One sees that as χ n increases, the populations of invasive glioma cells increase, they move faster toward the transfilter and divide faster in the lower chamber, all leading to increased total glioma populations. Fig. 6(C) and (D) show the tumor densities in the lower chamber and the corresponding number of migrated glioma cells at t = 36 h as a function of the haptotactic sensitivity χ 1 n . As expected, as χ 1 n increases, the number of migrating glioma cells increases, and they invade the lower chamber faster. We also investigated the combined effect of χ n and χ 1 n on the invasive glioma cell populations at 36 h (data not shown). Again, as expected, the results show that glioma cells invade faster when they have higher sensitivities of both haptotaxis and chemotaxis. Moreover, the combined effect is more evident in the left chamber due to the stronger interaction between tumor cells in the upper chamber and M1/M2 cells in the lower chamber.
If we increase the rate a 3 of differentiation of tumorsuppressive cells (M1) to tumor-enhancing cells (M2), the total population of microglia increases due to the higher proliferation rate of M2 cells, as shown in Fig. 7(A) . M1-and M2-dominant spatial profiles of microglia for lower (a 3 = 1.61 × 10 −3 ; red) and larger (a 3 = 1.61 × 10 −1 ; gray) transition rates, respectively, in the lower chamber at the final time n . As the haptotactic parameter (χ 1 n ) increases the tumor cells invade into the region initially occupied by the M1 cells more rapidly. Here and hereafter, cell numbers are derived from the continuum density using the total number of cells in [9] .
are shown in Fig. 7(B) . Fig. 7(C) shows the tumor density in the whole domain. For larger a 3 , more aggressive M2 cells in the lower chamber can interact with tumor cells in the upper chamber [red curve in Fig. 7(C) ]. This leads to an increased tumor population [first column in Fig. 7(D) ] and enhanced glioma inva- sion [second column in Fig. 7(D) ]. This enhanced invasiveness of the tumor cells is the result of the mutual interactions between tumor cells and the microglia. For large a 3 , the M1 type cells are completely converted into the M2 phenotype (solid red curves in Fig. 7 (E) and 7(F); a 3 = 1.61 × 10 −1 ), leading to efficient tumor invasion. However, when this transition rate is small (a 3 = 1.61 × 10 −3 ), the less effective M1 type persists in the lower chamber [black solid curve in Fig. 7(E) ] with less population of the M2 phenotype [black curve in Fig. 7(F) ]. This leads to slower production of TGF-β and lower MMP secretion by tumor cells, which in turn results in a reduction in the population of invasive glioma cells by more than 25% [see Fig. 7(D) ].
In Fig. 8 , we illustrate the effect of the M2 phenotype on the regulation of tumor cell invasion. As the secretion rate of EGF by M2 cells increases, the number of migrating tumor cells also increases (by 28%), since this leads to stronger interactions of M1 and M2 in the lower chamber with tumor cells in the upper chamber and faster growth of the latter. On the other hand, a decrease in the production rate B 2 of TGF-β by M2 cells results in a significant decrease (33%) in the number of migrating cells, due to a decreased gradient of TGF-β for chemotaxis and to partial inhibition of MMP production via TGF-β-MMP signaling, as found in the experiments [9] . Fig. 9 shows the results of simulating the population of migrating tumor cells for different values of the transfilter permeability γ 0 , which reflects the pore size in the membrane. One sees that as the membrane becomes more permeable to tumor cells, the number in the lower chamber increases, as expected. This is the result of the ease of crossing combined with the increased rate of proliferation in the higher EGF found in the lower chamber. In the experiments [9] , the pore size of the transmembrane was 12 μm, corresponding to γ 0 = 78.5 in the model. Cells cannot cross the transfilter when the pore size is much smaller than their diameter, which is reflected in Fig. 9(A) , albeit at a very low γ 0 , because the homogenization involves a limit as the pore size goes to zero [22] .
B. Sensitivity Analysis
The model developed in previous sections contains 34 parameters, many of which are available in the literature or which can be estimated, but there are some for which no experimental data are known. These parameters are χ n , χ a 2 , a 3 , a 4 , B 1 , B 2 , B 3 , γ C , γ M , and in order to determine how sensitive is the number of migratory glioma cells after 12, 24, or 36 h to these parameters, we have performed a sensitivity analysis using a method developed in [23] . We have chosen a physically reasonable range for each of these parameters, and divided each range into 1000 intervals of uniform length, with all other parameters fixed at values given in Tables I and II E , a 2 , a 3 , a 4 , B 1 , B 2 , B 3 , γ C , γ M ) are computed and recorded in Fig. 10 , which shows the sensitivities to parametric variations for populations of tumor cells: (n(t) = 
, and MMPs: (P (t) = Ω P (x, t) dx) at t = 12, 24, and 36 h. The results show that the tumor population is most strongly positively correlated with a E , moderately correlated with χ n and B 1 , and only weakly correlated with χ While the M1 population is insensitive to most parameters, it is, not surprisingly, negatively correlated with the transformation rate of type M1 to type M2 (a 3 ). On the other hand, the M2 phenotype is positively correlated with a 2 and a 4 , but is only weakly correlated with other parameters. One also sees that the ECM density is negatively correlated with a E , and that the growth rate of the M2 phenotype (a 4 ) is very sensitive to the M2 population level and the concentrations of EGF and TGF-β. Fig. 11 shows the PRCC values of the invasive tumor population in the lower chamber, which is defined asn + (t) = Ω − n(x, t) dx, at t = 12 (blue), 24 (green), 36 (red) h. The numbers of invasive cells are positively correlated with the parameters a E , B 1 , but not sensitive to χ n , χ a 2 , a 3 , a 4 , B 2 , B 3 , γ C , γ M . Thus, in particular, the invasive glioma population will increase significantly if either the EGF-stimulated growth rate of tumor cells (a E ) or the EGF production rate (B 1 ) from M2 microglia is increased. Significantly, and again unsurprisingly, the dependence of the invasive cell population on the chemotactic sensitivity χ n varies in time-it is initially strongly correlated, but at 36 h, the correlation is almost negligible.
C. Application of the Model
Bemis and Schedin [24] conducted experiments on the invasive nature of breast cancer cells in a Boyden invasion assay with 8-μm pores in the filter, and showed that the number of cells invading is significantly decreased (more than 50%) when an MMP inhibitor called tissue inhibitors of metalloproteinases (TIMP) is applied to the system [cf., Fig. 12(A) ]. In our model, blocking of MMP is implemented by setting a 9 , the MMP production rate coefficient in (13), to 0.05, which is 1% of the normal value. A simulation shows that after 36 h, the population of invading glioma cells in the lower chamber is reduced by approximately 70% [see Fig. 12(B) ], which is in good agreement with the experimental results shown in Fig. 12(B) . As shown in experiments, TIMP cannot block the invasion of tumor cells completely, but they do suggest that blocking MMP activity in the brain will also slow down the invasion of glioma cells into the brain stroma. Another potentially effective therapeutic approach to slowing invasion is to apply an antibody against TGF-β signaling [9] (also see Fig. 5 ), given its pivotal roles in tumorigenesis [25] . When we apply combined therapeutic strategies by TIMP and antibody, this completely blocked the glioma invasion in the system [+MG+TIMP+Ab in Fig. 12(B) ]. These silicoexperiments suggest that glioma invasion may be significantly slowed down by the combined drug, which blocks both MMP secretion and TβIIR (TGF-β receptors).
IV. CONCLUSION
Cell-cell signaling is an integral process in tumor growth, since many mutations and chromosomal changes affect signaling pathways involving growth factors or cytokines. Signaling frequently involves indirect interactions between spatially separated cell populations in the TME or between normoxic and hypoxic cells within a tumor. The "go-or-grow" behavior of glioma cells may depend on many microenvironmental factors, including glucose-induced upregulation of miR-451 and mTOR [26] . Despite uncertainty concerning the details of the M 1 → M 2 transition in gliomas, our model consistently predicts the role of GIMs in promoting glioma invasion in vitro. On the other hand, the presence of inhibitors of MMPs and of astrocytes was shown both experimentally and theoretically to block glioma invasion [27] , [28] , and we plan to investigate the role of the possibly continuous spectrum of the M 1 → M 2 transition and the role of inhibitory molecules in the regulation of glioma infiltration in future work. Factors such as cell packing density and anisotropy of transport through the tissue affect the signaling process, but despite its importance, experimental data on signaling within tumors is sparse. Thus, computational studies on the effects of these interactions on tumor invasion, such as those done in [29] and [30] , and on the sensitivity of the predictions to kinetic parameters, may provide insights to guide experiments aimed at the development of new therapeutic approaches.
